Nebivolol 1a Pharma (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol 1a Pharma, is a beta blocker presented as an oral tablet for oral use. It is indicated for patients with hypertension and for those with chronic heart failure, where it helps to reduce cardiovascular events and improve outcomes.

GNH USA supplies Nebivolol 1a Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable global distribution.

Nebivolol is a selective β1‑adrenergic blocker used in cardiovascular disease management.

- Hypertension: reduces systolic and diastolic blood pressure, helping patients reach target levels. - Chronic heart failure: improves left ventricular function and lowers the risk of hospitalization.

Nebivolol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort. - Dizziness or light‑headedness, especially on standing. - Fatigue or general tiredness. - Nasal congestion or rhinorrhoea. - Bradycardia: slower than normal heart rate. - Peripheral edema: swelling of the lower limbs.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to syncope. - Acute bronchospasm in patients with reactive airway disease. - Allergic reactions such as rash, pruritus or angio‑edema. - Hepatic enzyme elevation indicating liver stress. - Cardiovascular collapse in rare cases.

Before initiating Nebivolol therapy, clinicians should consider several safety measures.

- Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Cardiac function assessment: evaluate baseline heart rate and conduction abnormalities. - Asthma/COPD caution: use carefully in patients with reactive airway disease. - Discontinuation: avoid abrupt cessation to prevent rebound hypertension. - Hepatic impairment: dose adjustment may be needed in liver disease. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nebivolol can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Other β‑blockers: additive bradycardia and hypotension. - Calcium‑channel blockers (verapamil, diltiazem): increased risk of AV‑block and severe hypotension. - Strong CYP2D6 inhibitors (paroxetine, fluoxetine): may raise nebivolol plasma levels.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and blood pressure for additive effects. - Antidiabetic agents: watch for enhanced hypoglycaemia, especially insulin.